A thorough understanding of the multi-systemic consequences of the BRCA1 mutation carrier state, including how these consequences are altered as a consequence of age or menopausal status, and of their cell-nonautonomous effects on the tissues at elevated cancer risk in such carriers would accelerate progress toward these goals. Here, BRCA1 is linked to cancer.